APPLICATION
NDA201153
TYPE
NDA
ORIGINAL APPROVAL
2011-03-24
LATEST ACTION
2011-03-24
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
ZYCLARAPrescription
IMIQUIMOD 3.75% · CREAM · TOPICAL
Approval history
2011-03-24Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval · Original · standard — Summary Review ↗AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.